PICC catheter was inserted to superior vena cava through uninjured side basilic vein or median cubital vein for receving chemotherapy.

经患者肢贵要静脉、肘正中静脉将PICC导管置入腔静脉进行化疗。

The indication of these procedures and the methods of lymph node dissection, bronchoplasty and pulmonary artery reconstruction, and superior vena cava reconstruction have been discussed.

讨论了病选择，淋巴结廓清，支气管和肺管处理，以及腔静脉替换和修补。

Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.

结果全组患者无手死亡,腔静脉梗阻症状均明显改善。1人造管栓形成,经溶栓治疗痊愈。全组患者存活时间为6～30个月。

PICC catheter was inserted to superior vena cava through uninjured side basilic vein or median cubital vein for receving chemotherapy.

经者健侧上肢贵要静、肘正中静将PICC导管置入上腔静进行化疗。

The indication of these procedures and the methods of lymph node dissection, bronchoplasty and pulmonary artery reconstruction, and superior vena cava reconstruction have been discussed.

讨论了病例选择，淋巴结廓清，支气管和肺管处理，以及上腔静替换和修补。

Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.

结果者无手术死亡,术后上腔静梗阻症状均明显改善。1例术后人造管栓形成,经溶栓治疗后痊愈。者术后存活时间为6～30个月。

PICC catheter was inserted to superior vena cava through uninjured side basilic vein or median cubital vein for receving chemotherapy.

经患者健侧上肢贵要静脉、肘正中静脉将PICC导管置入上腔静脉进行化疗。

The indication of these procedures and the methods of lymph node dissection, bronchoplasty and pulmonary artery reconstruction, and superior vena cava reconstruction have been discussed.

讨论了病，淋巴结廓清，支气管肺管处理，以及上腔静脉替补。

Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.

结果全组患者无手术死亡,术后上腔静脉梗阻症状均明显改善。1术后人造管栓形成,经溶栓治疗后痊愈。全组患者术后存活时间为6～30个月。

PICC catheter was inserted to superior vena cava through uninjured side basilic vein or median cubital vein for receving chemotherapy.

经患者健侧上肢贵要静脉、肘正中静脉将PICC导管置入上腔静脉进行化疗。

The indication of these procedures and the methods of lymph node dissection, bronchoplasty and pulmonary artery reconstruction, and superior vena cava reconstruction have been discussed.

病例选择，淋巴廓清，支气管和肺管处理，以及上腔静脉替换和修补。

Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.

组患者无手术死亡,术后上腔静脉梗阻症状均明显改善。1例术后人造管栓形成,经溶栓治疗后痊愈。组患者术后存活时间为6～30个月。

PICC catheter was inserted to superior vena cava through uninjured side basilic vein or median cubital vein for receving chemotherapy.

经患者健侧上肢贵要静脉、肘正中静脉将PICC导管置入上腔静脉进行化疗。

The indication of these procedures and the methods of lymph node dissection, bronchoplasty and pulmonary artery reconstruction, and superior vena cava reconstruction have been discussed.

讨论了病例选择，淋巴结廓清，支气管和肺管处理，以及上腔静脉替换和修补。

Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.

结果组患者无手术死亡,术后上腔静脉梗阻症状均明显改善。1例术后人造管栓形成,经溶栓治疗后。组患者术后存活时间为6～30个月。

PICC catheter was inserted to superior vena cava through uninjured side basilic vein or median cubital vein for receving chemotherapy.

经患者健侧上肢贵要、肘正中PICC导管置入上腔进行化疗。

The indication of these procedures and the methods of lymph node dissection, bronchoplasty and pulmonary artery reconstruction, and superior vena cava reconstruction have been discussed.

讨论了病例选择，淋巴结廓清，支气管和肺管处理，以及上腔替换和修补。

Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.

结果全组患者无手术死亡,术后上腔阻症状均明显改善。1例术后人造管栓形成,经溶栓治疗后痊愈。全组患者术后存活时间为6～30个月。

PICC catheter was inserted to superior vena cava through uninjured side basilic vein or median cubital vein for receving chemotherapy.

经患者健侧上肢贵要静脉、肘正中静脉将PICC导管置入上腔静脉进行化疗。

The indication of these procedures and the methods of lymph node dissection, bronchoplasty and pulmonary artery reconstruction, and superior vena cava reconstruction have been discussed.

讨论了病，淋巴结廓清，支气管肺管处理，以及上腔静脉替补。

Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.

结果全组患者无手术死亡,术后上腔静脉梗阻症状均明显改善。1术后人造管栓形成,经溶栓治疗后痊愈。全组患者术后存活时间为6～30个月。

PICC catheter was inserted to superior vena cava through uninjured side basilic vein or median cubital vein for receving chemotherapy.

患者健侧上肢贵要静脉、肘正中静脉将PICC导置入上腔静脉进行化疗。

The indication of these procedures and the methods of lymph node dissection, bronchoplasty and pulmonary artery reconstruction, and superior vena cava reconstruction have been discussed.

讨论了病例选择，淋巴结廓清，支气和肺处理，以及上腔静脉替换和修补。

Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.

结果全组患者无手术死亡,术后上腔静脉梗阻症状均明显改善。1例术后人造栓形成,溶栓治疗后痊愈。全组患者术后存活时间为6～30个月。

PICC catheter was inserted to superior vena cava through uninjured side basilic vein or median cubital vein for receving chemotherapy.

经患者健侧上肢贵要静脉、肘正中静脉将PICC导管置入上腔静脉进行化疗。

The indication of these procedures and the methods of lymph node dissection, bronchoplasty and pulmonary artery reconstruction, and superior vena cava reconstruction have been discussed.

讨论了病，淋巴结廓清，支气管肺管处理，以及上腔静脉替补。

Among them locally advanced lung cancer in 6 cases,malignant thymoma in 3,seminoma in 1,Hodgkin lymphoma in 1,metastatic squama cancer in and angusty of superior vena cava in 1.

结果全组患者无手术死亡,术后上腔静脉梗阻症状均明显改善。1术后人造管栓形成,经溶栓治疗后痊愈。全组患者术后存活时间为6～30个月。